Sarah Jessica Parker ta yi magana game da hauhawar farashin EpiPen

Wadatacce

• Bita don

Haɓaka farashin kwanan nan da tsadar rayuwa na maganin rashin lafiyar allurar rigakafi, EpiPen, bai haifar da komai ba game da gobarar da aka yi kan masana'antar miyagun ƙwayoyi, Mylan, a wannan makon. Tun lokacin da suka fara kera EpiPen, farashin ya tashi da kusan kashi 550 cikin ɗari, alamar ban mamaki daga $ 57 da ta fara a lokacin da kamfanin ya fara samun haƙƙin sayar da maganin a 2007. Yanzu, wannan irin wannan maganin zai kashe ku fiye da $ 600 .Kuma samun inshora baya taimakawa sosai, tare da rahoton Bloomberg cewa ko da bayan an cire inshora EpiPens guda biyu zai kashe ku kusan $415. Lokacin da mutane da yawa (yawancinsu yara ne masu shekaru makaranta) waɗanda ke da matsanancin rashin lafiya, siyan EpiPens wajibi ne ko da kuwa farashin, don haka ba abin mamaki bane cewa wannan hauhawar farashin zai tura mutane-celebs cikin hargitsi. .

Tauraruwar daya da ta fi damuwa: Sarah Jessica Parker. A cikin sakon Instagram na baya-bayan nan, SJP ta ba da sanarwar cewa za ta kawo ƙarshen haɗin gwiwa tare da Mylan, wanda ta yi aiki tare da shi a wani kamfen na inganta wayar da kan jama'a game da anaphylaxis, rashin lafiyar rashin lafiyar. Batun ya kusanto kusa da gida ga Parker, saboda ɗanta James Wilkie yana da rashin lafiyar gyada sosai kuma yana dogaro da ɗaukar EpiPen tare da shi koyaushe. Ta bayyana shawararta, inda ta tabbatar da cewa ta fito fili game da dalilin da yasa take raba hanya da masana'antar magunguna.

Ta rubuta cewa: "Na bar takaici, bakin ciki, da matukar damuwa da ayyukan Mylan," in ji ta. "Ban yarda da wannan shawarar ba kuma na kawo karshen alakar da ke tsakanina da Mylan sakamakon hakan kai tsaye. Ina fatan za su yi la'akari sosai kan fitar da muryoyin miliyoyin mutanen da ke dogaro da na'urar, kuma su dauki matakin gaggawa don ragewa. kudin. "

Parker ba shine kawai mai buguwa mai nauyi da yayi magana ba. Amurka A Yau rahoton cewa Fadar White House da Hillary Clinton sun kuma yi Allah wadai da ayyukan Mylan, lura da cewa yana haifar da wasu tambayoyi na ɗabi'a game da kamfanin. Tun bayan koma bayan da aka yi, Mylan ya fitar da wata sanarwa inda ya sanar da cewa za su rufe har dala 300 daga cikin kudin da ba a cikin aljihu na maganin a kantin magani, tare da rage nauyin kudi ga marasa lafiya da rabi. Kamfanin ya ce zai kuma fadada shirin taimakon marassa lafiya, wanda zai taimaka wa wadanda ba su da inshora ko marasa inshora. Rahotanni sun ce wannan shawarar za ta kashe Mylan kusan kashi 10 na jimillar kudaden shiga da ake sa ran samu ga magungunan Jaridar Wall Street Journal.

Duk da yake wannan ma'auni na ɗaukar tsada tabbas mataki ne kan madaidaiciyar hanya, a farashin ko'ina daga $ 115- $ 300 cike takardar sayan EpiPen har yanzu ba ta da arha - kuma ba cika Rx ba kawai zaɓi bane ga waɗanda ke da matsananciyar wahala. bukatar shi. Bari mu yi fatan Mylan da sauran masana'antun magunguna a duk faɗin ƙasar suna jin kukan marasa lafiya, iyaye, da 'yan siyasa, kuma ku tuna cewa ba za mu tsaya ga waɗannan hauhawar farashin cikin shiru ba.

Bita don